Epirubicin Market - Pronounce growth in upcoming years 2022 -2028 described in a new market report

The global Epirubicin Market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028.

Epirubicin hydrochloride is a class of drugs termed anthracyclines and is primarily used to treat breast cancers after surgical resection. Anthracyclines are antibiotics isolated from the gram-positive bacteria Streptomyces. They are commonly used as chemotherapy agents and exert their antineoplastic effects by targeting the replication of DNA. Epirubicin HCl is often preferred over anthracycline doxorubicin as it has been shown to have fewer side effects. Epirubicin HCl became FDA-approved (Food and Drug Administration) as adjuvant therapy for treating axillary node-positive breast cancers following resection under the trade name Ellence in 1999.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00073584?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. Pfizer, Inc.
2. Teva Pharmaceutical Industries Ltd.
3. Salius Pharma Pvt Ltd
4. Areva Pharmaceuticals Mylan N. V.
5. Hikma Pharmaceuticals PLC
6. Fresenius Kabi AG
7. Miracalus Pharma Pvt. Ltd.

In this report, the market has been segmented on the basis of:

Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial and 200mg/Vial)
Application (Breast cancer, Liver Cancer, Bladder Cancer, and Others)
Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies)

Access full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/epirubicin-market

The growing pharmaceutical industry worldwide is also likely to create growth opportunities for the epirubicin market. The US pharmaceutical market is the largest and the most commercial market in North America. The US alone holds over 45% of the global pharmaceutical market. The majority of the top global drug manufacturing companies are from the US, and the nation has been at the forefront of biomedical research.

Further, the pharmaceutical market in Germany holds the fourth position in the global pharmaceutical market with small and mid-sized companies. According to the International Trade Administration (ITA), in 2019, the pharmaceutical market in Germany accounted for US$ 62.5 billion. The country is likely to remain one of the most attractive destinations for the global pharmaceutical industry in the coming years in terms of manufacturing and supply. The market is driven by factors such as increasing investment in research and development and growing patent applications.

Order a copy of this research report at @: https://www.premiummarketinsights.com/buy/TIP00073584?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.